BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1685004)

  • 1. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa; Isakov VA
    Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N; Miwa T
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; intermittent and long-term administration].
    Sakai H; Oka H; Sakaguchi M
    Nihon Rinsho; 1988 Jan; 46(1):114-8. PubMed ID: 2897481
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical use of histamine-2 receptor antagonists.
    Michocki RJ; Richardson JP
    Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
    Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; inhibitors of initiating factors causing peptic ulcer].
    Ishikawa M; Saito H; Sato J
    Nihon Rinsho; 1988 Jan; 46(1):69-78. PubMed ID: 2897486
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modified H2 receptor blockers in ulcus therapy].
    Domschke S; Domschke W
    Dtsch Med Wochenschr; 1982 Dec; 107(48):1827-30. PubMed ID: 6128214
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug therapy of peptic ulcers].
    Fukutomi H; Nakahara A
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):47-54. PubMed ID: 1673704
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maintenance treatment of peptic ulcer and their problems].
    Iwasaki A; Matsuo Y
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):55-9. PubMed ID: 1673705
    [No Abstract]   [Full Text] [Related]  

  • 14. [The status of H2-blocker therapy today].
    Rameis H
    Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine v. cimetidine in peptic ulcer.
    Drug Ther Bull; 1982 Jul; 20(15):57-9. PubMed ID: 6128213
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 17. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedtime treatment of duodenal ulcer.
    Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.